Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001567619-18-003898

Options or other derivatives

  • Director disposed of 130,849 shares (other)

From the SEC's structured data for this filing

Trades in this filing

KIRK RANDAL J · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-10-05 Other disposition : show line 1 in the form Series 1 Preferred Stock −130,849 0 I
Loading xslF345X03/doc1.xml…